Happiness Biotech Group Limited HAPP
$ 4.5
1.35%
Annual report 2022
added 08-16-2022
Happiness Biotech Group Limited Balance Sheet 2011-2024 | HAPP
Annual Balance Sheet Happiness Biotech Group Limited
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | - | -7.39 M | -2.32 M | - | - | - | - | - | - |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 209 K | - | - | - | - | - | - |
Total Current Liabilities |
17.9 M | 15.1 M | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
20 M | 15.1 M | 5.51 M | 4.76 M | 8.84 M | 18.2 M | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
12.3 M | 61.5 M | 68.7 M | 56 M | 35.3 M | 17.8 M | - | - | - | - | - | - |
Total Assets |
97.4 M | 113 M | 85.1 M | 65.7 M | 53.4 M | 41.5 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
19.7 M | 36.6 M | 33.7 M | 14.8 M | 8.88 M | - | - | - | - | - | - | - |
Book Value |
77.4 M | 97.6 M | 79.6 M | 60.9 M | 44.6 M | 23.3 M | - | - | - | - | - | - |
Total Shareholders Equity |
78.1 M | 94.7 M | 79.6 M | 60.9 M | 44.6 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Happiness Biotech Group Limited
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | 15.1 M | - | 5.88 M | - | 5.51 M | - | - | - | 4.76 M | - | - | - | 8.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | - | - | - | 61.5 M | - | 69.4 M | - | 66.6 M | - | - | - | 53.9 M | - | - | - | 35.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | - | - | - | 113 M | - | 93.6 M | - | 85.1 M | - | - | - | 65.7 M | - | - | - | 53.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | - | - | - | 36.6 M | - | 43.8 M | - | 33.7 M | - | 23.8 M | - | 14.8 M | - | - | - | 8.88 M | - | - | - | 4.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | - | - | - | 97.6 M | - | 87.7 M | - | 79.6 M | - | - | - | 60.9 M | - | - | - | 44.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | - | - | - | 94.7 M | - | 87.6 M | - | 79.6 M | - | 66.2 M | - | 60.9 M | - | - | - | 44.6 M | - | - | - | 23.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency